BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19039267)

  • 1. Small malignant hepatic tumor detection in gadolinium- and ferucarbotran-enhanced magnetic resonance imaging: does combining ferucarbotran-enhanced T2*-weighted gradient echo and T2-weighted turbo spin echo images have additive efficacy?
    Kim YK; Lee YH; Kwak HS; Kim CS; Han YM
    Korean J Radiol; 2008; 9(6):510-9. PubMed ID: 19039267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.
    Tang Y; Yamashita Y; Arakawa A; Namimoto T; Mitsuzaki K; Abe Y; Katahira K; Takahashi M
    AJR Am J Roentgenol; 1999 Jun; 172(6):1547-54. PubMed ID: 10350287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma: detection with gadolinium- and ferumoxides-enhanced MR imaging of the liver.
    Pauleit D; Textor J; Bachmann R; Conrad R; Flacke S; Layer G; Kreft B; Schild H
    Radiology; 2002 Jan; 222(1):73-80. PubMed ID: 11756708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-liver contrast and subjective tumor conspicuity of respiratory-triggered T2-weighted fast spin-echo sequence compared with T2*-weighted gradient recalled-echo sequence for ferucarbotran-enhanced magnetic resonance imaging of hepatic malignant tumors.
    Ishiyama K; Hashimoto M; Izumi J; Watarai J; Shibata S; Sato T; Yamamoto Y
    J Magn Reson Imaging; 2008 Jun; 27(6):1322-6. PubMed ID: 18504744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of small (Tonan T; Fujimoto K; Azuma S; Ono N; Matsushita S; Kojiro M; Hayabuchi N
    Eur J Radiol; 2007 Oct; 64(1):133-9. PubMed ID: 17408900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superparamagnetic iron oxide (SPIO)-enhanced liver MRI with ferucarbotran: efficacy for characterization of focal liver lesions.
    Namkung S; Zech CJ; Helmberger T; Reiser MF; Schoenberg SO
    J Magn Reson Imaging; 2007 Apr; 25(4):755-65. PubMed ID: 17335040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant hepatic tumor detection with ferumoxide-enhanced magnetic resonance imaging: is chemical-shift-selective fat suppression necessary for fast spin-echo sequence?
    Goshima S; Kanematsu M; Matsuo M; Kondo H; Kako N; Yokoyama R; Hoshi H; Moriyama N
    J Magn Reson Imaging; 2004 Jul; 20(1):75-82. PubMed ID: 15221811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of well-differentiated hepatocellular carcinomas from other hepatocellular nodules in cirrhotic liver: value of SPIO-enhanced MR imaging at 3.0 Tesla.
    Park HS; Lee JM; Kim SH; Chang S; Kim SJ; Han JK; Choi BI
    J Magn Reson Imaging; 2009 Feb; 29(2):328-35. PubMed ID: 19161184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of ferucarbotran-enhanced fluid-attenuated inversion-recovery echo-planar, T2-weighted turbo spin-echo, T2*-weighted gradient-echo, and diffusion-weighted echo-planar imaging for detection of malignant liver lesions.
    Fukukura Y; Kamiyama T; Takumi K; Shindo T; Higashi R; Nakajo M
    J Magn Reson Imaging; 2010 Mar; 31(3):607-16. PubMed ID: 20187203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of liver metastases: Gadoxetic acid-enhanced three-dimensional MR imaging versus ferucarbotran-enhanced MR imaging.
    Kim YK; Lee YH; Kwak HS; Kim CS; Han YM
    Eur J Radiol; 2010 Jan; 73(1):131-6. PubMed ID: 18996659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
    Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
    Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of hepatocellular carcinoma with ferucarbotran (resovist)-enhanced breath-hold MR imaging: feasibility of 10 minute-delayed images.
    Saito K; Shindo H; Ozuki T; Ishikawa A; Kotake F; Shimazaki Y; Abe K
    Magn Reson Med Sci; 2008; 7(3):123-30. PubMed ID: 18827455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of combining sequentially acquired gadobenate dimeglumine-enhanced magnetic resonance imaging and resovist-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: comparison with computed tomography hepatic arteriography and computed tomography arterioportography using 16-slice multidetector computed tomography.
    Kim YK; Kwak HS; Han YM; Kim CS
    J Comput Assist Tomogr; 2007; 31(5):702-11. PubMed ID: 17895780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging.
    Nasu K; Kuroki Y; Nawano S; Kuroki S; Tsukamoto T; Yamamoto S; Motoori K; Ueda T
    Radiology; 2006 Apr; 239(1):122-30. PubMed ID: 16493012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of portal perfusion abnormalities: comparison of 3 ferucarbotran-enhanced magnetic resonance imaging sequences.
    Iwazawa J; Nishida N; Yamamoto A; Nango M; Ninoi T; Murakami Y; Nakamura K; Inoue Y
    J Comput Assist Tomogr; 2006; 30(2):165-72. PubMed ID: 16628027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conspicuity of zones of ablation after radiofrequency ablation in porcine livers: comparison of an extracellular and an SPIO contrast agent.
    Bangard C; Stippel DL; Berg F; Kasper HU; Hellmich M; Fischer JH; Hölscher A; Lackner K; Gossmann A
    J Magn Reson Imaging; 2008 Jul; 28(1):263-70. PubMed ID: 18581392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant hepatic tumor detection with ferumoxides-enhanced MR imaging with a 1.5-T system: comparison of four imaging pulse sequences.
    Kanematsu M; Itoh K; Matsuo M; Maetani Y; Ametani F; Kondo H; Kato H; Hoshi H
    J Magn Reson Imaging; 2001 Feb; 13(2):249-57. PubMed ID: 11169831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved detection of hepatic metastases from pancreatic cancer using periodically rotated overlapping parallel lines with enhanced reconstruction (PROPELLER) technique after SPIO administration.
    Hirokawa Y; Isoda H; Okada T; Arizono S; Shimada K; Yamamoto A; Shibata T; Togashi K
    Invest Radiol; 2010 Mar; 45(3):158-64. PubMed ID: 20142748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dimensional dynamic liver MR imaging using sensitivity encoding for detection of hepatocellular carcinomas: comparison with superparamagnetic iron oxide-enhanced mr imaging.
    Kim YK; Kim CS; Kwak HS; Lee JM
    J Magn Reson Imaging; 2004 Nov; 20(5):826-37. PubMed ID: 15503325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular lesions with increased iron uptake on superparamagnetic iron oxide-enhanced magnetic resonance imaging in cirrhosis or chronic hepatitis: comparison of four magnetic resonance sequences for lesion conspicuity.
    Tanabe M; Ito K; Shimizu A; Fujita T; Onoda H; Yamatogi S; Washida Y; Matsunaga N
    Magn Reson Imaging; 2009 Jul; 27(6):801-6. PubMed ID: 19144487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.